Clinical TopicsWeb Exclusives

FDA permits marketing of balloon device for Eustachian tube dysfunction

Share

On Sept. 16, the Food and Drug Administration (FDA) permitted marketing of the Aera system, a device that uses a small balloon to treat persistent Eustachian tube dysfunction. Read more

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Test Your Knowledge

Which of the following statements accurately describes hypertrophic cardiomyopathy (HCM)?

Recent Posts